Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2025
Reporting Period Referenced: Third quarter ended September 30, 2025
This filing serves as a notification that the company will host a conference call on October 30, 2025, to discuss third-quarter 2025 results and provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding an upcoming conference call rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document solely references the upcoming release of third-quarter results.
Guidance, Outlook, and Management Commentary
Upcoming Event: A conference call is scheduled for Thursday, October 30, 2025, at 4:30 p.m. Eastern Time.
Agenda: Discussion of third-quarter 2025 results and a corporate update.
Exhibits: A press release dated October 23, 2025, is attached as Exhibit 99.1 and incorporated by reference.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for preliminary details.
- Confirm the date and time of the conference call (October 30, 2025, 4:30 p.m. ET) to access management commentary.
- Monitor for the subsequent filing of the Form 10-Q for the quarter ended September 30, 2025, for audited financial data.